• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经内分泌分化是Ⅲ-Ⅳ期结直肠癌的一个相关预后因素。

Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer.

作者信息

Grabowski P, Schindler I, Anagnostopoulos I, Foss H D, Riecken E O, Mansmann U, Stein H, Berger G, Buhr H J, Scherübl H

机构信息

Medizinische Klinik I, Universitätsklinikum Benjamin Franklin, FU Berlin, Germany.

出版信息

Eur J Gastroenterol Hepatol. 2001 Apr;13(4):405-11. doi: 10.1097/00042737-200104000-00018.

DOI:10.1097/00042737-200104000-00018
PMID:11338071
Abstract

OBJECTIVE

To determine the prognostic relevance of neuroendocrine differentiation in colorectal cancer.

METHODS

The survival of 116 patients with colorectal cancer of stages III (n = 59) and IV (n = 57) was correlated with the extent of neuroendocrine differentiation. Chromogranin A and synaptophysin were used as neuroendocrine markers. Based on the degree of immunoreactivity for these markers, tumours were classified as 0 (no expression of neuroendocrine markers), 1 (< 2% cells staining positive for neuroendocrine markers) and 2 (> 2% cells staining positive for neuroendocrine markers). Patients were followed up for more than 5 years or until death.

RESULTS

Seven of 59 (11.8%) stage III cancers and 13/57 (22.8%) stage IV cancers belonged to group 2. The 96 patients of groups 0 and 1 lived for 48.9 months, whereas the 20 patients of group 2 survived for only 18.6 months (Kaplan-Meier survival curves, P < 0.001). The difference was most striking in stage III disease with 79.4 months' survival for combined groups 0 and 1, and 38.9 months' survival for group 2 (P < 0.01). Using the multivariate Cox regression model, the presence of more than 2% of cells with neuroendocrine differentiation was found to be an independent prognostic parameter for stage III and IV disease. No correlation was observed between neuroendocrine differentiation and tumour location, grade, depth of invasion or stage.

CONCLUSION

Neuroendocrine differentiation is often seen in colorectal cancer. It is an independent prognostic factor in stage III-IV colorectal cancer.

摘要

目的

确定神经内分泌分化在结直肠癌中的预后相关性。

方法

116例III期(n = 59)和IV期(n = 57)结直肠癌患者的生存情况与神经内分泌分化程度相关。嗜铬粒蛋白A和突触素用作神经内分泌标志物。根据这些标志物的免疫反应程度,肿瘤被分类为0(无神经内分泌标志物表达)、1(<2%细胞神经内分泌标志物染色阳性)和2(>2%细胞神经内分泌标志物染色阳性)。对患者进行了超过5年的随访或直至死亡。

结果

59例III期癌症中有7例(11.8%),57例IV期癌症中有13例(22.8%)属于2组。0组和1组的96例患者生存了48.9个月,而2组的20例患者仅存活了18.6个月(Kaplan-Meier生存曲线,P < 0.001)。在III期疾病中差异最为显著,0组和1组合并后的生存期为79.4个月,2组为38.9个月(P < 0.01)。使用多变量Cox回归模型,发现神经内分泌分化细胞超过2%的存在是III期和IV期疾病的独立预后参数。未观察到神经内分泌分化与肿瘤位置、分级、浸润深度或分期之间的相关性。

结论

神经内分泌分化在结直肠癌中常见。它是III-IV期结直肠癌的独立预后因素。

相似文献

1
Neuroendocrine differentiation is a relevant prognostic factor in stage III-IV colorectal cancer.神经内分泌分化是Ⅲ-Ⅳ期结直肠癌的一个相关预后因素。
Eur J Gastroenterol Hepatol. 2001 Apr;13(4):405-11. doi: 10.1097/00042737-200104000-00018.
2
Is neuroendocrine differentiation a prognostic factor in poorly differentiated colorectal cancer?神经内分泌分化是低分化结直肠癌的一个预后因素吗?
World J Surg Oncol. 2017 Mar 28;15(1):71. doi: 10.1186/s12957-017-1139-y.
3
Heterogeneous expression of neuroendocrine marker proteins in human undifferentiated carcinoma of the colon and rectum.
Ann N Y Acad Sci. 2004 Apr;1014:270-4. doi: 10.1196/annals.1294.030.
4
The clinical significance of neuroendocrine differentiation in T3-T4 node-negative colorectal cancer.T3-T4期无淋巴结转移结直肠癌中神经内分泌分化的临床意义
Int J Surg Pathol. 2010 Jun;18(3):201-6. doi: 10.1177/1066896909332112. Epub 2009 Apr 15.
5
Analysis of neuroendocrine differentiation and the p53/BAX pathway in UICC stage III colorectal carcinoma identifies patients with good prognosis.对国际抗癌联盟(UICC)III期结直肠癌中神经内分泌分化及p53/BAX途径的分析可识别出预后良好的患者。
Int J Colorectal Dis. 2006 Apr;21(3):221-30. doi: 10.1007/s00384-005-0779-5. Epub 2005 Jun 14.
6
Expression of neuroendocrine markers: a signature of human undifferentiated carcinoma of the colon and rectum.
Virchows Arch. 2002 Sep;441(3):256-63. doi: 10.1007/s00428-002-0650-9. Epub 2002 Jun 7.
7
Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer.乳腺癌神经内分泌分化的组织芯片分析及其预后意义
Hum Pathol. 2003 Oct;34(10):1001-8. doi: 10.1053/s0046-8177(03)00411-8.
8
[Association of neuroendocrine differentiation with progression and prognosis of gastric adenocarcinoma].神经内分泌分化与胃腺癌进展及预后的相关性
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2016 Jan;45(1):24-30. doi: 10.3785/j.issn.1008-9292.2016.01.04.
9
[Clinicopathological features of colorectal neuroendocrine neoplasms and prognostic significance of WHO staging system].[结直肠神经内分泌肿瘤的临床病理特征及世界卫生组织分期系统的预后意义]
Zhonghua Bing Li Xue Za Zhi. 2013 Mar;42(3):191-6. doi: 10.3760/cma.j.issn.0529-5807.2013.03.011.
10
[Clinicopathologic characteristics of colorectal neuroendocrine tumor].[结直肠神经内分泌肿瘤的临床病理特征]
Korean J Gastroenterol. 2006 Aug;48(2):97-103.

引用本文的文献

1
Case report: Coexistence of rectal signet ring cell carcinoma with neuroendocrine components.病例报告:直肠印戒细胞癌合并神经内分泌成分
BMC Geriatr. 2025 May 28;25(1):382. doi: 10.1186/s12877-025-06037-x.
2
ENO2-derived phosphoenolpyruvate functions as an endogenous inhibitor of HDAC1 and confers resistance to antiangiogenic therapy.ENO2 衍生的磷酸烯醇丙酮酸作为 HDAC1 的内源性抑制剂发挥作用,并赋予对血管生成抑制治疗的抗性。
Nat Metab. 2023 Oct;5(10):1765-1786. doi: 10.1038/s42255-023-00883-y. Epub 2023 Sep 4.
3
A "conversion-deterioration-double mutation" theory for the evolution and progression of colorectal cancer.
结直肠癌发生发展的“转化-恶化-双重突变”理论。
Cancer Med. 2022 Jul;11(13):2601-2611. doi: 10.1002/cam4.4637. Epub 2022 Mar 13.
4
Prognostic Value of Immunohistochemical Markers for Locally Advanced Rectal Cancer.局部进展期直肠癌免疫组化标志物的预后价值
Molecules. 2022 Jan 18;27(3):596. doi: 10.3390/molecules27030596.
5
Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker?传统结直肠癌中的神经内分泌分化:偶然发现还是预后生物标志物?
Cancers (Basel). 2021 Oct 12;13(20):5111. doi: 10.3390/cancers13205111.
6
An in vitro vascularized micro-tumor model of human colorectal cancer recapitulates in vivo responses to standard-of-care therapy.体外血管化的人类结直肠癌细胞微肿瘤模型重现了对标准治疗的体内反应。
Lab Chip. 2021 Apr 7;21(7):1333-1351. doi: 10.1039/d0lc01216e. Epub 2021 Feb 19.
7
Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you?免疫组织化学在神经内分泌肿瘤的诊断和分类中的应用:棕色能为你做些什么?
Hum Pathol. 2020 Feb;96:8-33. doi: 10.1016/j.humpath.2019.12.002. Epub 2019 Dec 17.
8
Neuroendocrine differentiation is predictive of poor survival in patients with stage II colorectal cancer.神经内分泌分化可预测II期结直肠癌患者的不良生存情况。
Oncol Lett. 2017 Apr;13(4):2230-2236. doi: 10.3892/ol.2017.5681. Epub 2017 Feb 7.
9
A novel histologic grading scheme based on poorly differentiated clusters is applicable to treated rectal cancer and is associated with established histopathological prognosticators.一种基于低分化细胞簇的新型组织学分级方案适用于经治疗的直肠癌,且与既定的组织病理学预后指标相关。
Cancer Med. 2016 Jul;5(7):1510-8. doi: 10.1002/cam4.740. Epub 2016 May 11.
10
Brachyury identifies a class of enteroendocrine cells in normal human intestinal crypts and colorectal cancer.Brachyury蛋白可识别正常人类肠道隐窝和结直肠癌中的一类肠内分泌细胞。
Oncotarget. 2016 Mar 8;7(10):11478-86. doi: 10.18632/oncotarget.7202.